| Literature DB >> 20943207 |
Anna Skoczyńska1, Ewa Sadowy, Katarzyna Bojarska, Janusz Strzelecki, Alicja Kuch, Agnieszka Gołębiewska, Izabela Waśko, Małgorzata Foryś, Mark van der Linden, Waleria Hryniewicz.
Abstract
The objectives of this study were to assess the incidence of invasive pneumococcal disease (IPD) in Poland (2006-2009), where mass vaccination had not been implemented, and to determine the serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates. The IPD incidence rates were highest among children under 2 years of age (3.39/100,000 in 2009) and children 2-5 years old (2.44/100,000). The most common serotypes were 14, 3, 1, 4, 19F, 23F, 6B, and 12F (61.7% of all isolates). In children aged less than 5 years, isolates of serotypes 14, 6B, and 19F were most prevalent (52.7% of the IPD cases). The PCV7, PCV10, and PCV13 covered 43.3%, 54.8%, and 68.8% of all IPD cases, and 68.7%, 76.3%, and 86.3% of cases involving children under 5 years of age. Penicillin resistance was found in 21.3% of the isolates responsible for meningitis and in 1.2% of isolates responsible for other invasive infections. Introduction of antipneumococcal conjugated vaccines into the national immunisation programme would likely lead to a significant reduction of IPD-associated morbidity among Polish children in particular, as well as in the population as a whole, especially in cases involving pneumococci with a decreased susceptibility to antibiotics.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20943207 DOI: 10.1016/j.vaccine.2010.09.100
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641